DS
THRN

David Shaw’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

David Shaw’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,224
Closed -$175K – 6110
2021
Q4 		$175K Buy
+28,224
New +$221K ﹤0.01% 4930

Other funds holding THRN

DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

David Shaw's THRN Position: Q1 2022 in Review

David Shaw sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q1 2022, closing a stake of 28,224 shares — an estimated $175K sold.

David Shaw first reported a position in THRN in Q4 2021 and held it in 1 quarter. The position peaked at $175K in Q4 2021. 48 funds tracked by Wall St. Rank hold THRN as of Q1 2022.

  • David Shaw reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • David Shaw sold 28,224 Thorne Healthtech, Inc. Common Stock shares in Q1 2022, an estimated $175K.
  • David Shaw first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • David Shaw's Thorne Healthtech, Inc. Common Stock position peaked at $175K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.